218 related articles for article (PubMed ID: 31429520)
1. A prognostic 10-lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients.
Tang J; Ren J; Cui Q; Zhang D; Kong D; Liao X; Lu M; Gong Y; Wu G
J Cell Mol Med; 2019 Oct; 23(10):6775-6784. PubMed ID: 31429520
[TBL] [Abstract][Full Text] [Related]
2. A prognostic eight-lncRNA expression signature in predicting recurrence of ER-positive breast cancer receiving endocrine therapy.
Tang J; Cui Q; Zhang D; Kong D; Liao X; Ren J; Gong Y; Wu G
J Cell Physiol; 2020 May; 235(5):4746-4755. PubMed ID: 31663114
[TBL] [Abstract][Full Text] [Related]
3. A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer.
Liu Z; Mi M; Li X; Zheng X; Wu G; Zhang L
J Cell Mol Med; 2020 Nov; 24(21):12444-12456. PubMed ID: 32967061
[TBL] [Abstract][Full Text] [Related]
4. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
5. Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction.
Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
DNA Cell Biol; 2019 Dec; 38(12):1529-1539. PubMed ID: 31647329
[TBL] [Abstract][Full Text] [Related]
6. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
7. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
8. An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment.
Tang J; Cui Q; Zhang D; Liao X; Zhu J; Wu G
J Cell Mol Med; 2019 Aug; 23(8):4980-4990. PubMed ID: 31124293
[TBL] [Abstract][Full Text] [Related]
9. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
10. A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.
Huang TB; Dong CP; Zhou GC; Lu SM; Luan Y; Gu X; Liu L; Ding XF
Int Urol Nephrol; 2017 May; 49(5):825-835. PubMed ID: 28188414
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.
Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ
J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405
[TBL] [Abstract][Full Text] [Related]
13. An integrated mRNA-lncRNA signature for relapse prediction in laryngeal cancer.
Xiang Y; Li C; Liao Y; Wu J
J Cell Biochem; 2019 Sep; 120(9):15883-15890. PubMed ID: 31062433
[TBL] [Abstract][Full Text] [Related]
14. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.
Liu D
Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968
[TBL] [Abstract][Full Text] [Related]
15. A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy.
Sun M; Liu X; Xia L; Chen Y; Kuang L; Gu X; Li T
Biochem Pharmacol; 2021 Jul; 189():114285. PubMed ID: 33069665
[TBL] [Abstract][Full Text] [Related]
16. Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients.
Zhou M; Zhong L; Xu W; Sun Y; Zhang Z; Zhao H; Yang L; Sun J
Sci Rep; 2016 Aug; 6():31038. PubMed ID: 27503456
[TBL] [Abstract][Full Text] [Related]
17. An immune-related prognostic signature for predicting breast cancer recurrence.
Tian Z; Tang J; Liao X; Yang Q; Wu Y; Wu G
Cancer Med; 2020 Oct; 9(20):7672-7685. PubMed ID: 32841536
[TBL] [Abstract][Full Text] [Related]
18. Development of a Ten-lncRNA Signature Prognostic Model for Breast Cancer Survival: A Study with the TCGA Database.
Zhou W; Pang Y; Yao Y; Qiao H
Anal Cell Pathol (Amst); 2020; 2020():6827057. PubMed ID: 32908814
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis identifies a novel lncRNA prognostic signature associated with aerobic glycolysis and hub pathways in breast cancer.
Li Z; Zheng J; Feng Y; Li Y; Liang Y; Liu Y; Wang X; Yang Q
Cancer Med; 2021 Nov; 10(21):7877-7892. PubMed ID: 34581026
[TBL] [Abstract][Full Text] [Related]
20. A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen.
Wang K; Li J; Xiong YF; Zeng Z; Zhang X; Li HY
Sci Rep; 2018 Feb; 8(1):3179. PubMed ID: 29453409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
